Home › Acute Myeloid Leukemia › New Jersey › Clifton
Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Clifton, NJ
Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Clifton. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Nagre-recruitPhase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Nagre-recruitPhase 3
- Hackensack University Medical Center, Hackensack · 7 mi ang layo
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Nagre-recruitPhase 2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi ang layo
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi ang layo
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 3
- Hackensack University Medical Center, HMH, Hackensack · 7 mi ang layo
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Nagre-recruitPhase 2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Nagre-recruitPhase 2/3
- John Theurer Cancer Center / Hackensack University, Hackensack · 7 mi ang layo
Phase IB/II of CPX-351 for Relapse Prevention in AML
Nagre-recruitPhase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi ang layo
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Nagre-recruitPhase 1
- Hackensack University Medical Center, Hackensack · 7 mi ang layo
Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod
- Houston, TX85 pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Seattle, WA41 pag-aaral
- Baldwin Park, CA40 pag-aaral
- Columbus, OH35 pag-aaral
- Philadelphia, PA34 pag-aaral
- Durham, NC33 pag-aaral
- Atlanta, GA31 pag-aaral
- Tampa, FL29 pag-aaral
- Chicago, IL26 pag-aaral
- Portland, OR25 pag-aaral
Iba pang pag-aaral sa Clifton
- Non-Small Cell Lung Cancer24 pag-aaral
- Kanser (lahat ng uri)15 pag-aaral
- Multiple Myeloma14 pag-aaral
- Metastatic Cancer12 pag-aaral
- Kanser sa Suso12 pag-aaral
- Kanser sa Prostate12 pag-aaral
- Kanser sa Ovary11 pag-aaral
- Kanser sa Baga10 pag-aaral
- Colorectal Cancer8 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg8 pag-aaral
- Kanser ng Endometrium8 pag-aaral
- Pagkabigo ng Puso8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.